歡喜傳媒(01003.HK)與中國移動(00941.HK)旗下咪咕文化展開戰略合作
歡喜傳媒(01003.HK)公布,於9月28日與中國移動(00941.HK)旗下咪咕文化簽署協議,展開戰略合作,將在多方面展開合作,包括聯合投資多部影片,同時「歡喜首映」會於中國移動的咪咕大屏側「點播數字院線」及小屏端「咪咕視頻APP」設立「歡喜首映廳」專區。
雙方並將緊密合作,聯合投資更多的優質影視內容,首部合作電影為高群書監製的《龍門相》,將於9月30日在「歡喜首映」和中國移動5G FUN映廳「歡喜首映廳」專區聯合獨播。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.